Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Plant Physiol ; 119(4): 1535-46, 1999 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10198113

RESUMEN

The flavoprotein (R)-(+)-mandelonitrile lyase (MDL; EC 4.1.2.10), which plays a key role in cyanogenesis in rosaceous stone fruits, occurs in black cherry (Prunus serotina Ehrh.) homogenates as several closely related isoforms. Biochemical and molecular biological methods were used to investigate MDL microheterogeneity and function in this species. Three novel MDL cDNAs of high sequence identity (designated MDL2, MDL4, and MDL5) were isolated. Like MDL1 and MDL3 cDNAs (Z. Hu, J.E. Poulton [1997] Plant Physiol 115: 1359-1369), they had open reading frames that predicted a flavin adenine dinucleotide-binding site, multiple N-glycosylation sites, and an N-terminal signal sequence. The N terminus of an MDL isoform purified from seedlings matched the derived amino acid sequence of the MDL4 cDNA. Genomic sequences corresponding to the MDL1, MDL2, and MDL4 cDNAs were obtained by polymerase chain reaction amplification of genomic DNA. Like the previously reported mdl3 gene, these genes are interrupted at identical positions by three short, conserved introns. Given their overall similarity, we conclude that the genes mdl1, mdl2, mdl3, mdl4, and mdl5 are derived from a common ancestral gene and constitute members of a gene family. Genomic Southern-blot analysis showed that this family has approximately eight members. Northern-blot analysis using gene-specific probes revealed differential expression of the genes mdl1, mdl2, mdl3, mdl4, and mdl5.


Asunto(s)
Aldehído-Liasas/genética , Frutas/enzimología , Frutas/genética , Isoenzimas/genética , Aldehído-Liasas/química , Aldehído-Liasas/metabolismo , Secuencia de Aminoácidos , Secuencia de Bases , Dominio Catalítico/genética , Cisteína/química , Cartilla de ADN/genética , ADN Complementario/genética , Flavina-Adenina Dinucleótido/metabolismo , Frutas/crecimiento & desarrollo , Expresión Génica , Genes de Plantas , Glicosilación , Isoenzimas/química , Isoenzimas/metabolismo , Datos de Secuencia Molecular , Familia de Multigenes , Señales de Clasificación de Proteína/genética , Homología de Secuencia de Aminoácido
2.
J Cardiovasc Pharmacol ; 24(4): 603-11, 1994 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-7528843

RESUMEN

We tested the hypothesis that acute, intravenous (i.v.) magnesium (Mg2+) supplementation would protect against myocardial stunning in an in situ swine model of regional ischemia and reperfusion and that a concomitant inhibitory effect on platelet aggregation would be elicited. An open-chest model was used, with transient occlusion of the left anterior descending coronary artery (LAD) for 8 min. Regional contractile function was assessed by measuring wall thickening fraction with epicardial Doppler crystals. One control group (n = 6) and two treatment groups were studied: group I (n = 6) received 750 mg MgSO4 before occlusion; group II (n = 6) received 1 g MgSO4 after the occlusion. Both protocols produced significant hypermagnesemia. In group I, platelet aggregation was measured before and after Mg2+ treatment using platelet-rich plasma (PRP) and various agonists (ADP 5 and 10 mM and collagen 1 mg/ml). As compared with controls, both treatment groups experienced significantly less postischemic dysfunction, with systolic function returning more quickly to baseline. Furthermore, platelet aggregation was significantly decreased immediately after Mg2+ infusion. Inhibition of platelet aggregation induced by Mg2+ treatment occurs concomitantly with significant amelioration of postischemic myocardial dysfunction.


Asunto(s)
Magnesio/uso terapéutico , Isquemia Miocárdica/prevención & control , Aturdimiento Miocárdico/prevención & control , Animales , Femenino , Hemodinámica/efectos de los fármacos , Infusiones Intravenosas , Magnesio/sangre , Modelos Cardiovasculares , Contracción Miocárdica/efectos de los fármacos , Reperfusión Miocárdica , Agregación Plaquetaria/efectos de los fármacos , Porcinos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA